Frequency of patients in the study (%) | Frequency of (+) results (%) | Changed w/+result (%) | Changed w/−result (%) | % changed Overall | |
Stage II | |||||
Low risk | 30 | 10 | 75 | 20 | 25.5 |
High risk | 15 | 25 | 75 | 20 | 33.8 |
All stage | 20 | 28.3 | |||
Stage III | |||||
IIIa | 15 | 20 | 30 | 50 | 46.0 |
IIIb | 20 | 30 | 30 | 25 | 26.5 |
IIIc | 20 | 35 | 30 | 25 | 26.8 |
All stage III | 31.8% | 31.9% | |||
All stages combined | 26.50% | 30.26% |